News
CADTH has received the following notice(s) of pending drug submission(s).
Brand name
TBC
Generic name
glucagon
Manufacturer
Eli Lilly Canada Inc.
Indication(s)
Severe hypoglycemic reactions
Project Number
SR0626-000
Call for patient input
2019-06-25
Patient input d...
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
We are pleased to announce that process and operational changes have been made to transition Cancer Drug Implementation Advisory Committee (CDIAC) functions to CADTH effective July 1, 2019. These changes will further enhance the transparency of the CADTH pan-Canadian Oncology Drug Review (pCODR) review process and better support public pay...
CADTH has received the following notice(s) of pending drug submission(s).
Brand name
Ilumya
Generic name
tildrakizumab
Manufacturer
Sun Pharma Canada
Indication(s)
Psoriasis, moderate to severe plaque
Project Number
SR0624-000
Call for patient input
2019-06-11
Pati...
CADTH has received the following notice(s) of pending drug submission(s).
Brand name
TBC
Generic name
upadacitinib
Manufacturer
AbbVie
Indication(s)
Arthritis, Rheumatoid
Project Number
SR0614-000
Call for patient input
2019-05-31
Patient input deadline
2019-07-...
